DUBLIN, October 4, 2017 /PRNewswire/ --
The "Global Antibiotics Market 2017-2021" report has been added to Research and Markets' offering.
The report forecasts the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021.
The report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is the strategic alliances and mergers and acquisitions (M&A). Formation of strategic alliances, in terms of licensing and collaboration, help in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertize from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company.
According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases. Globally, there has been an increase in the number individuals affected by infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases. Demographic changes caused by increased globalization and urbanization are a major factor leading to the global emergence of infectious diseases.
Further, the report states that one of the major factors hindering the growth of this market is the development of antibiotic-resistant strains. The development of multidrug-resistant microbes is one of the major threats to the human health in the present days. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. The antibiotic resistance usually develops due to the irrational use of these drugs.
Other prominent vendors
- Actelion Pharmaceuticals
- Basilea Pharmaceutica
- Bayer HealthCare
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Antibiotics: An Overview
Part 06: Veterinary Drug Approval Process
Part 07: Antibiotic Resistance: An Overview
Part 08: Market Landscape
Part 09: Pipeline Landscape
Part 10: Market Segmentation By Chemical Class
Part 11: Market Segmentation By Drug Origin
Part 12: Market Segmentation By Mechanism Of Action
Part 13: Market Segmentation By Application
Part 14: Market Segmentation By Spectrum
Part 15: Geographical Segmentation
Part 16: Decision Framework
Part 17: Drivers And Challenges
Part 18: Market Trends
Part 19: Vendor Landscape
Part 20: Key Vendor Analysis
Part 21: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/stw5z4/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets